Speeding innovation for industry
Success | Diagnosis and innovative treatment
Esprimed allows medical centers to simulate, calculate, and optimize the doses delivered by their interventional radiology equipment.
Founded by former healthcare professionals in 2009, Esprimed offers high-quality services that are backed by an ambitious R&D strategy. The startup has become France’s top name for quality control in the field of nuclear medicine.
Esprimed helps hospitals with equipment monitoring, dose optimization strategies, and radiation exposure prevention. In addition, the startup offers radioprotection and medical physics consulting services. Esprimed’s second line of business, interventional radiology, has been growing since 2012. The company signed a framework agreement with the CEA for the development of advanced dose calculation tools and their integration into a virtual-reality radiology room.
At the end of 2014, List granted the startup exclusive rights to use the technologies that power List’s em.dose tool, which performs advanced delivered-dose calculations and estimates the associated radiological risks to align with public health recommendations.
Resources and skills
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.